SC Pharmaceuticals Inc (SCPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 36,332 | 13,593 | 0 | 0 | 0 |
| Cost of Goods | 11,361 | 3,811 | N/A | N/A | N/A |
| Gross Profit | 24,971 | 9,782 | N/A | N/A | N/A |
| Operating Expenses | 90,108 | 65,989 | 36,157 | 25,823 | 29,933 |
| Operating Income | -64,776 | -55,396 | -36,157 | -25,823 | -29,933 |
| Interest Expense | 7,570 | 8,123 | 3,302 | 2,575 | 2,587 |
| Other Income | -12,802 | 8,709 | 2,621 | 364 | 311 |
| Pre-tax Income | -85,148 | -54,810 | -36,838 | -28,034 | -32,209 |
| Net Income Continuous | -85,148 | -54,810 | -36,838 | -28,034 | -32,209 |
| Net Income | $-85,148 | $-54,810 | $-36,838 | $-28,034 | $-32,209 |
| EPS Basic Total Ops | -1.91 | -1.42 | -1.30 | -1.02 | -1.31 |
| EPS Basic Continuous Ops | -1.91 | -1.42 | -1.30 | -1.02 | -1.31 |
| EPS Diluted Total Ops | -1.91 | -1.42 | -1.30 | -1.02 | -1.31 |
| EPS Diluted Continuous Ops | -1.91 | -1.42 | -1.30 | -1.02 | -1.31 |
| EPS Diluted Before Non-Recurring Items | -1.53 | -1.42 | -1.30 | -1.02 | -1.31 |
| EBITDA(a) | $-64,756 | $-55,372 | $-36,120 | $-25,385 | $-29,534 |